How does "pattern care" differ from "step therapy"? Does the bionic pancreas work? Why is incretin therapy taking off? Here, a 5-slide review of these and other hot topics from the 2014 ADA Scientific Sessions.
Hot topics at the 2014 ADA Scientific Sessions included insulin-incretin combination therapy; results of first use of the bionic pancreas; vitamin D deficiency and insulin sensitivity; and more. (Image courtesy of Wikimedia Commons.)
In pattern care, you work to reduce FPG and PPG at the same time using a combination of oral and injectable drugs, including basal and rapid-acting insulin, DPP-4 inhibitors, and GLP-1 RAs. More, here
A new study finds that replacing vitamin D helps reduced adipose tissue fibrosis and improves insulin sensitivity in persons at risk for type 2 diabetes. More, here
When used in young patients, the bionic pancreas delivered blood sugar levels that trended toward normal-a 60% reduction in low sugars and an 88% reduction in nocturnal hypoglycemia.More, here
Improved quality of dietary intake helps reduce the risk of type 2 diabetes, independent of other healthy behaviors like increased exercise and weight loss. More, here
DPP-4 inhibitors and GLP-1 RAs have a very low risk of hypoglycemia and the GLP-1 RAs also promote weight loss--making both are attractive alone or in combination with insulin. More, here
